CHICAGO TRUST Co NA boosted its holdings in Cigna Group (NYSE:CI – Free Report) by 281.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,014 shares of the health services provider’s stock after buying an additional 2,963 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Cigna Group were worth $1,071,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in CI. Norges Bank bought a new stake in shares of Cigna Group in the fourth quarter worth approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. lifted its position in Cigna Group by 13,333.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after purchasing an additional 3,141,844 shares during the period. Capital Research Global Investors boosted its holdings in Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after purchasing an additional 1,855,897 shares during the last quarter. Dodge & Cox grew its position in Cigna Group by 19.7% in the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the period. Finally, Boston Partners raised its stake in Cigna Group by 314.6% during the 4th quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock valued at $450,856,000 after buying an additional 1,243,056 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Cigna Group Stock Performance
NYSE:CI opened at $276.67 on Thursday. The stock has a 50-day simple moving average of $284.61 and a two-hundred day simple moving average of $279.09. Cigna Group has a 52-week low of $239.51 and a 52-week high of $332.29. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market capitalization of $73.19 billion, a PE ratio of 11.73, a P/E/G ratio of 1.06 and a beta of 0.29.
Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were paid a dividend of $1.56 per share. The ex-dividend date was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.
Analyst Upgrades and Downgrades
CI has been the topic of several research analyst reports. Jefferies Financial Group lowered their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a report on Monday, April 20th. Raymond James Financial set a $340.00 price objective on Cigna Group in a research report on Friday, May 1st. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, June 20th. Guggenheim upped their price target on shares of Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Finally, Barclays cut shares of Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $310.00 to $304.00 in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $338.30.
Read Our Latest Stock Analysis on Cigna Group
Insider Activity at Cigna Group
In other news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by insiders.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
